Oxidative stress‐related biomarkers in essential hypertension and ischemia‐reperfusion myocardial damage

R Rodrigo, M Libuy, F Feliú, D Hasson - Disease markers, 2013 - Wiley Online Library
Cardiovascular diseases are a leading cause of mortality and morbidity worldwide, with
hypertension being a major risk factor. Numerous studies support the contribution of reactive …

[HTML][HTML] Coenzyme Q10: Clinical applications in cardiovascular diseases

A Martelli, L Testai, A Colletti, AFG Cicero - Antioxidants, 2020 - mdpi.com
Coenzyme Q 10 (CoQ 10) is a ubiquitous factor present in cell membranes and
mitochondria, both in its reduced (ubiquinol) and oxidized (ubiquinone) forms. Its levels are …

Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease

BJ Lee, YC Huang, SJ Chen, PT Lin - Nutrition, 2012 - Elsevier
OBJECTIVE: The purpose of this study was to investigate the effect of coenzyme Q10
supplementation on oxidative stress and antioxidant enzyme activity in patients with …

Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease

RB Singh, MA Niaz, SS Rastogi, PK Shukla… - Journal of human …, 1999 - nature.com
In a randomised, double-blind trial among patients receiving antihypertensive medication,
the effects of the oral treatment with coenzyme Q10 (60 mg twice daily) were compared for 8 …

Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey

ES Ford, JC Will, BA Bowman… - American Journal of …, 1999 - academic.oup.com
Little is known about carotenoids, a diverse group of plant compounds with antioxidant
activity, and their association with diabetes, a condition characterized by oxidative stress …

Does diabetes mellitus increase the requirement for vitamin C?

JC Will, T Byers - Nutrition reviews, 1996 - academic.oup.com
This paper reviews the scientific evidence regarding the vitamin C status of people with
diabetes mellitus and whether they might have increased dietary vitamin C requirements …

Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction

RB Singh, GS Wander, A Rastogi, PK Shukla… - … drugs and therapy, 1998 - Springer
The effects of oral treatment with coenzyme Q10 (120 mg/d) were compared for 28 days in
73 (intervention group A) and 71 (placebo group B) patients with acute myocardial infarction …

Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction

RB Singh, NS Neki, K Kartikey, D Pella… - Molecular and cellular …, 2003 - Springer
In a randomized, double-blind, controlled trial, the effects of oral treatment with coenzyme
Q10 (CoQ10, 120 mg/day), a bioenergetic and antioxidant cytoprotective agent, were …

A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction

RB Singh, MA Niaz, P Agarwal… - Postgraduate …, 1996 - academic.oup.com
In a randomised, double-blind placebo-controlled trial, the effects of the administration of
oral L-carnitine (2 g/day) for 28 days were compared in the management of 51 (carnitine …

Vitamins and cardiovascular disease

S Honarbakhsh, M Schachter - British Journal of Nutrition, 2008 - cambridge.org
CVD is a major cause of mortality and morbidity in the Western world. In recent years its
importance has expanded internationally and it is believed that by 2020 it will be the biggest …